Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy

NCT00693485 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-Angle

Interventions

DRUG: 400 ug Brimonidine Implant
DRUG: 200 ug Brimonidine Implant
DRUG: Sham (no implant)

Sponsor

Allergan